The project is one of a series initiated at the request of the Commission's Agricultural Services (DG VI) to provide RMs in support of Community Policy banning the use of growth promoting compounds in farm animals and the Directives laying down requirements for monitoring of undesirable substances in farm animals and products in Member States (86/469/EEC) and laying down criteria for reference methods used in pursuance of the monitoring programs (87/410/EEC).
Beta-agonists are a group of pharmacologically active compounds which are well established for treatment of specific conditions such as asthma in man. They are also approved for specified veterinary treatments. A more recently discovered effect of these drugs is that they alter the growth of animals either by increasing growth rate or more importantly by repartitioning nutrients in favour of the production of more lean meat and less fat. The compounds are known to be widely used illegally in meat producing animals to yield leaner higher value meat.
They are routinely monitored in Member States with the National Monitoring programs. Monitoring may be in urine or meat. Some 12 of these compounds have been identified as having been used for illegal purposes in farm animals.
The project will consist in the preparation of a number of materials such as lyophilised urine, muscle and liver from animals:
- treated with either clenbuterol or salbutamol or cimaterol (pigs only)
- never treated with beta-agonists.
The materials are mainly intended for use by the National control laboratories.
Preparation of materials and initial stability studies will be completed in 1992.
Funding SchemeCSC - Cost-sharing contracts
28110 Algete (Madrid)
15310 Aghia Paraskevi (Athens)
92390 Villeneuve La Garenne